Why Hormone Replacement Therapy May Be Safer Than You Think

The pendulum has swung from one extreme to the other when it comes to hormone replacement therapy (HRT) to treat symptoms of menopause. At first, the replacement hormones—mostly a combination of estrogen and progestin to replace what the body stops making after menopause—were seen as a panacea. Doctors thought they could not only relieve hot flashes and night sweats, but also prevent chronic aging diseases like heart problems and weakening bones. But studies then found that the supplement hormones could lead to a higher risk of breast cancer—and that they didn’t protect the heart after all. In the latest study on the subject, published in JAMA, researchers led by Dr. JoAnn Manson from the division of preventive medicine at Brigham and Women’s Hospital report on the longest follow-up of the original hormone therapy study, which used data from the Women’s Health Initiative. More than 27,000 women who were randomly assigned to receive either a placebo, a combination of hormones (estrogen plus progestin) or estrogen alone if they had had a hysterectomy. They were followed for 18 years and tracked for chronic diseases like cancer, as well as heart attack and deaths. The women took the hormone therapy for five to seven years. By the end of the 18-year study, the death rates from any cause among the women receiving some form of hormone therapy were similar to that of women who took the placebo. MORE: Hormone Replacement Therapy After Menopause: W...
Source: TIME.com: Top Science and Health Stories - Category: Consumer Health News Authors: Tags: Uncategorized Drugs estrogen Hormone Therapy hormones for menopause hot flashes night sweats progestin Reproductive Health treating menopause Source Type: news

Related Links:

Cancer is one of the leading causes for the morbidity and mortality worldwide. Although substantial studies have been conducted theoretically and experimentally in recent years, it is still a challenge to expl...
Source: BMC Systems Biology - Category: Molecular Biology Authors: Tags: Software Source Type: research
Lab Chip, 2018, Accepted Manuscript DOI: 10.1039/C8LC01071D, PaperPeng Zhang, Jennifer Crow, Divya Jyothi Lella, Xin Zhou, Glenson Samuel, Andrew K Godwin, Yong Zeng Extracellular vesicles (EVs) present a promising liquid biopsy for cancer diagnosis. However, it remains a daunting challenge to quantitatively measure molecular contents of EVs including tumor-associated mRNAs. Herein, we report... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Lab Chip latest articles - Category: Chemistry Authors: Source Type: research
Dalton Trans., 2018, Accepted Manuscript DOI: 10.1039/C8DT03948H, CommunicationYuanyuan You, Ni Wang, Lizhen He, Changzheng Shi, Dong Zhang, Yiyong Liu, Liangping Luo, Tianfeng Chen Herein we design and synthesize a cell penetration peptide- and cancer-targeted molecule-functionalized multi-walled carbon nanotube for precise orthotopic glioma therapy. This nanosystem demonstrates improved cancer recognition, blood-brain barrier (BBB) penetration,... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Dalton Trans. latest articles - Category: Chemistry Authors: Source Type: research
At a time when most gadgets, on average, last only a handful of years, it’s heartening to note that one of the most complex technological instruments ever built is still going strong. On Nov. 20, the International Space Station (ISS) reached a two-decade milestone since the launch of its first module. Beyond just a feat of engineering, the ISS serves as an all too rare example in this hyper-partisan era of what can be achieved when our desire to cooperate triumphs over our divisions. It was on this day in 1998 that aerospace engineers from former rivals Russia and the United States celebrated the lift off of the Mosc...
Source: TIME: Science - Category: Science Authors: Tags: Uncategorized onetime overnight space Source Type: news
The number of surgeries for pelvic organ prolapse in the United States is increasing. Abdominal sacrocolpopexy has become the gold standard for women desiring a restorative repair of their apical pelvic organ prolapse. Despite the associated morbidity of abdominal sacrocolpopexy, advances in minimally invasive approaches have safely increased the number of these surgeries performed, especially among urologists. Moreover, a number of studies have demonstrated superior objective outcomes after abdominal sacrocolpopexy when compared with vaginal approaches. Variations in the technique are described, but no consensus exists on...
Source: Urologic Clinics of North America - Category: Urology & Nephrology Authors: Source Type: research
Several transvaginal mesh products have been marketed to address vaginal vault prolapse. Although data are limited, prolapse recurrence rates and subjective outcome measures seem to be equivalent for vaginal mesh compared with native tissue apical prolapse repair, and the different vaginal meshes have not proven superior to one another. Given the known unique complications specific to vaginal mesh with equivalent outcomes for the apical vaginal prolapse, it is reasonable to reserve mesh use for specific high-risk cases, such as patients with large apical prolapse recurrence after native tissue repair who are not candidates for sacrocolpopexy.
Source: Urologic Clinics of North America - Category: Urology & Nephrology Authors: Source Type: research
An estimated 300,000 women undergo pelvic organ prolapse (POP) surgery in the United States every year at a cost of more than 1 billion dollars per year. The prevalence of POP is approximately 2.9% to 8%, and increases with age. Apical support is required to achieve successful prolapse repair. As the search for the safest, most durable, surgical repair continues, transvaginal native tissue repairs have the advantage of providing minimally invasive surgical repairs without the added risk of abdominal, laparoscopic, or robotic surgery while avoiding the risk of mesh augmentation.
Source: Urologic Clinics of North America - Category: Urology & Nephrology Authors: Source Type: research
One percent to 2% of children in the United States are confirmed victims of child abuse, with many more likely affected. It can be difficult to diagnose, with often misleading medical histories, but acute care providers should be aware of its presenting wa...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
Neuropathic diabetic foot ulceration (DFU) is a serious problem that is increasing in frequency given the epidemic of diabetes in the United States. Standard treatment, as outlined in the Society for Vascular Surgery DFU guidelines, has focused on wound offloading to relieve pressure, control of infection and wound bioburden, revascularization, and focused wound dressings. However, even in specialized wound treatment programs, the average healing time for DFUs is 4 to 6  months. During this prolonged treatment time, the wound is susceptible to the development of wound infection, increased tissue loss, osteomyelitis, a...
Source: Journal of Vascular Surgery - Category: Surgery Authors: Tags: From bench to bedside Source Type: research
McLean, in his letter to the editor, suggested that the conclusions made in our manuscript1 may be the result of Simpson's paradox. In other words, he believes that our results would have been different had we combined the US Sarcoma Collaborative and National Cancer Database (NCDB) patients and analyzed them collectively.
Source: Journal of the American College of Surgeons - Category: Surgery Authors: Tags: Letter Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer of the Uterus | Cardiology | Endometrial Cancer | Health | Heart | Heart Attack | Heart Disease | Hormonal Therapy | Hormone Replacement Therapy | Hormones | Hospitals | Hysterectomy | Men | Menopause | Orthopaedics | Osteoporosis | Science | Study | USA Health | Women